Related Experiment Video
Updated: May 18, 2026
11:48
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Macrophage migration inhibitory factor covalently complexed with phenethyl isothiocyanate
Joel D A Tyndall1, Hongqi Lue, Malcolm T Rutledge
1School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand.
Summary
Phenethyl isothiocyanate irreversibly inhibits macrophage migration inhibitory factor by binding to a hydrophobic pocket. This structural modification alters protein interactions, offering new targets for anti-inflammatory and anticancer drug design.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Macrophage migration inhibitory factor (MIF) plays a role in inflammation and cancer.
- Phenethyl isothiocyanate (PEITC) is a natural compound with anti-inflammatory and anticancer properties.
Purpose of the Study:
- To elucidate the structure of MIF modified by PEITC.
- To understand the molecular basis of PEITC's inhibitory action on MIF.
- To identify potential targets for novel therapeutic inhibitor design.
Main Methods:
- X-ray diffraction was used to determine the structure of the modified MIF protein at 1.64 Å resolution.
Main Results:
- PEITC covalently binds within a deep hydrophobic pocket between MIF subunits.
- The secondary structure of MIF remains unchanged, but significant side-chain and main-chain rearrangements occur (e.g., Tyr37, residues 31-34).
- These conformational changes may reduce the binding affinity of modified MIF to its receptor, CD74.
Conclusions:
- The crystal structure reveals the precise binding site and conformational changes induced by PEITC.
- The identified binding pocket and areas of conformational change are key targets for designing more selective and potent MIF inhibitors.
- This research provides a structural basis for developing PEITC-derived therapeutics for inflammatory and cancerous conditions.
